INTERVENTIONAL CARDIOLOGY st Annual International Symposium March 6-11, 2016

Transcription

1 3/6/16 INTERVENTIONAL CARDIOLOGY st Annual International Symposium March 6-11, 2016 Sunday, March 6, :00 10:00 AM Morning Session Russian Session Chairman: Evgeny Merkulov, MD, PhD Comparison of Three Types of Transradial Closure Devices Evgeny Merkulov, MD, PhD Left Main PCI: Predictors of Short and Long Term Prognosis, Seven Year Follow-up Katherine Shreyder, MD, PhD CTO PCI in Patients with Low Ejection Fraction Vsevolod Mironov, MD, PhD TAVR in Low Calcified Critical Aortic Stenosis Aleksey Protopopov, MD, PhD How to Achieve both Coronary Arteries with Only One Approach During CTO PCI Alexandr G. Osiev, MD, PhD STEMI Care in Big Territory and Low Population Density Regions Russian Experience Aleksey Protopopov, MD, PhD American Session I STEMI Care in Big Territory and Low Population Density Regions American Experience Charles Bethea, MD, FACC CTOs in America Have we Caught up with the Japanese? James R.Margolis, MD, FACC 27 Year Experience with Stem Cell Therapies Howard Leonhardt

2

3 Sunday, March 6, :30 6:00 PM Afternoon Session Oral Abstract Session I Early Mechanical Support in Stress-induced Cardiogenic Shock Daryl Sudasena, MD American Session I, continued Stem Cells: State of the Union Timothy D. Henry, MD, FACC TAVR Session Chairmen: James R. Margolis MD, FACC, Raj Makkar, MD, FACC Imaging Leaflet Abnormalities After TAVR Raj Makkar, MD, FACC Portico Valve Raj Makkar, MD, FACC Balloon Expandable vs. Self-expanding Valves: Advantages and Disadvantages; Which Should be Used When? Raoul Bonan, MD Lotus Valve Christopher Meduri, MD, MPH TAVR Optimization: Improving Outcomes and Reducing Cost Christopher Meduri, MD, MPH Valve for Life New Project for TAVR in Europe Dariusz Dudek, MD Mini Symposium on Neuroprotection DWI MRI Lessons as Surrogates of Cognitive Dysfunction and Sub-clinical Stroke Kevin Abrams, MD Cerebral Embolization Complicating All Invasive Cardiovascular Procedures: Extent of the Problem Andreas Baumbach, MD

4 Peri-TAVR Clinical Stroke is Only the Tip of the Iceberg: The NeuroTAVR and DEFLECT III Study, NeuroARC Initiative Alexandra Lansky, MD, FACC SOLACI Session: ST Elevation Myocardial Infarction: The Latin American Perspective Chairman: Jorge Atilio Belardi, MD, FACC Treatment of STEMI: Argentina Stent for Life Program Jorge Atilio Belardi, MD, FACC Current Controversis in Antiplateltes and Anticoagulation in STEMI Luis Guzmán, MD, FACC STEMI: Radial Approach for All Comers, the Uruguay Experience Ricardo Lluberas, MD

5 Monday, March 7, :00 10:00 AM Morning Session American Session II Mitral Valve Symposium Chairmen: William O Neill, MD, FACC, Saibal Kar, MD, FACC, Mitral Clipping Saibal Kar, MD, FACC, Transcatheter Mitral Valves Overview William O Neill, MD, FACC Tendyne Valve System William O Neill, MD, FACC Neovasc Tiara Valve System William O Neill, MD, FACC Antegrade Approach to TMVR William O Neill, MD, FACC TMVR vs. Mitral Clipping vs. Open Repair Brian Bethea, MD Management of Paravalvular Leak Raj Makkar, MD, FACC Valve in Valve for Treatment of Degenerative Mitral Prosthesis William O Neill, MD, FACC LA Appendage Closure: Tips and Tricks Saibal Kar, MD, FACC First In-human Transcatheter Tricuspid Valve Repair in a Patient with Severely Regurgitant Tricuspid Valve Saibal Kar, MD, FACC

6 Monday, March 7, :30 6:00 PM Afternoon Session Oral Abstract Session II Improved Balloon Angioplasty: Lessons Learned from Stent and Drug Coated Balloon Trials Ronald J. Solar, PhD Korean Session Chairmen: Seung-Jung Park, MD, PhD, FACC, and Hyo-Soo Kim, MD, PhD Comparative Effectiveness of Several Types of DES in Real-world: Data from the IRIS-DES Registry Duk-Woo Park, MD, PhD Long-term Impact of Successful CTO Intervention from ASAN CTO Registry Duk-Woo Park, MD, PhD PCI vs. CABG in Left Main and 3 Vessel Disease: What We ve Learned from PRECOMBAT, BEST, and NEW YORK Registries Seung-Jung Park, MD, PhD, FACC Application of Non-invasive Hemodynamic Assessment: Beyond the FFR Bon-Kwon Koo, MD, PhD CT-based Myocardial Segmentation: Novel Method and Clinical Application Young-Hak Kim, MD, PhD Evaluation of Mitral Valve Disease Using 3D Echocardiography Jong-Min Song, MD, PhD New Oral Anticoagulant Differentiation Global and within Asia Kee-Joon Choi, MD Implications of Calcification in TAVI Hyo-Soo Kim, MD, PhD The Asian TAVR Registry: What is the Difference? Sung-Han Yoon, MD

7 Balkan Session Chairman: Ðeiti Prvulovi, MD, PhD Software to Monitor PCI for Coronary Bifurcation Disease: A Register, an Informer and the Base for Future Clinical Research Ðeiti Prvulovi, MD, PhD Left Radial Approach in Patients with ST-elevation Myocardial Infarction Undergoing Primary PCI Hrvoje Pintari, MD, PhD Multivessel Disease Diagnosed at a Time of Primary PCI: The Results for Prague 13 Trial Ota Hlinomaz, MD, PhD Special Session 6:30 9:30 PM Buffet Dinner (Family Invited) PCI Then and In the Future Many of today s interventional cardiologists were not yet born when Andreas Grüntzig did the first PTCA procedure in September, Many others were still young children; and a minority of those practicing today wasere practicing in the pre-stent era. The introduction of the Wallstent, Gianturco- Roubin and Palmaz-Schatz stents completely changed the interventional cardiology landscape. But the early days of stenting brought a whole new set of problems that had to be solved before stenting could become mainstream. Over many centuries delivery of healthcare has been a constantly evolving process. These changes parallel new developments in understanding and treatment. As the pace of advancements has accelerated rapidly in recent decades, changes in delivery have lagged behind - and/or changes have been inappropriate. The healthcare system as we know it today is radically different from what it was only thirty years ago. Thirty years from now (or even ten years from now), even more radical changes can be expected. Peter Fitzgerald has been on the cutting edge of innovation for many decades. He is uniquely qualified to give us a glimpse into the future. The First Coronary Stent - Background and Development: What it was like before stents? Post stent management before Clopidogrel James R. Margolis, MD, FACC The Digital Health Ecosystem - Modulating Medical Innovation and Healthcare Efficiency Peter Fitzgerald, MD, PhD, FACC

8 Tuesday, March 8, :00 10:00 AM Morning Session Scandinavian Session Chairmen: Andrejs Erglis, MD, PhD, FACC, M. Pauliina Margolis, MD, PhD, and Kari I. Saunamäki, MD, PhD The Danish Team STEMI and Non-culprit Artery Revascularization: The Present State of the Evidence from DANAMI-3/Primulti and Related Studies Kari I. Saunamäki, MD, PhD TAVI Complications: Overview and Case Story Jan Ravkilde, MD, PhD The Notion Trial: (SAVR vs TAVI in Allcomers Down to 70 Years) Peter Clemmensen, MD, DMSci Is Biodegradable Drug-eluting Stent a Class Effect? Update from the SORT OUT Programme Lisette Okkels Jensen, MD, DMSci Stent Thrombosis After PPCI Treated with Bivalirudin Realities and Solutions Peter Clemmensen, MD, DMSci Update on Long Term Follow Up in the Nordic Bifurcation Trials: Focus on Kissing vs. No Kissing and 1 vs. 2 Stents Evald Christiansen, MD, PhD The Latvian Team Do Bioresorbable Vascular Scaffolds (BVS) Open a New Era on Post-PCI Patient Followup? News From the Heartflow FFRCT Analysis Dace Sondore, MD, PhD Future Options for Modulation of the Sympathetic Nervous System: Device Based Aortic Arch Electrical Stimulation for the Treatment of Heart Failure Andrejs Erglis, MD, PhD, FACC Regenerative Medicine in Cardiology and Beyond: Current Therapies and Future Concepts at the Latvian Centre of Cardiology Ieva Briede, MD Insights into Latvian Registry of Renal Artery Stenting Karlis Štrenge, MD

9 A Synergy of Drug Eluting Stent and Bioresorbable Scaffold for the Treatment of Distal Left Main Bifurcation Andrejs Erglis, MD, PhD, FACC Central/Eastern European Session I: Coronary Revascularization Chairmen: Dariusz Dudek, MD, PhD, and Jacek Legutko, MD, PhD Implementation of the Novel Algorithm of Paramedic Service for Rapid Diagnosis and Direct Cathlab Transfer of Patients with Acute Coronary Syndromes (STEMI and High Risk NSTE ACS): The Polish Experience Tomasz Rakowski, MD, PhD OCT-guided PCI in ACS Tomasz Pawlowski, MD

10 Tuesday, March 8, :30 6:00 PM Afternoon Session Oral Abstract Session III A Rare Case of Stroke in Young Male Caused by Takayasu Arteritis Erika Adam, MD Central/Eastern European Session II Chairmen: Dariusz Dudek, MD, PhD, and Jacek Legutko, MD, PhD Does the DES Strut Thickness Impact Mid- and Long-term Results? Robert J. Gil, MD, PhD How to Optimize Left Main PCI in Complex Cases Jacek Legutko, MD, PhD Mini Symposium: Bioreabsorbable Scaffolds (BRS): Clinical Data and Everyday Practice Bioreabsorbable Scaffolds: Clinical Evidence and Limitations of the First Generation Devices Dariusz Dudek, MD, PhD Endothelial Independent Vasomotion after BVS ABSORB Implantation Lukasz Rzeszutko, MD OCT/IVUS Imaging of Plaque Redistribution after Implantation of Metallic DES and BVS ABSORB Wojciech Wojakowski, MD, PhD Complex Bifurcation Stenting with BRS: What Have we Learned from the OCT Imaging? Maciej Lesiak, MD, PhD Direct BVS ABSORB Implantation in AMI Stanislaw Bartus, MD, PhD One-Year Clinical, Angiographic and OCT Follow-up after BVS Implantation in Long Coronary Artery Lesions: Comparison with Everolimus Eluting Stent Oleg Polonetsky, MD Bioreabsorbable Scaffolds in Coronary CTO Lesions: Long-term Clinical and Angiographic Follow-up Maciej Lesiak, MD, PhD

11 Intravascular Imaging to Guide BRS Transplantation OCT vs. IVUS Marcin Wizimirski, RT Bioreabsorbable Scaffolds: What Should We Expect within the Next Five Years? Dariusz Dudek, MD, PhD

12 Wednesday, March 9, :00 10:00 AM Morning Session American Session III Chairman: Richard R. Heuser, MD, FACC A New Approach to Complex PVD: Percutaneous Bypass Richard R. Heuser, MD, FACC PCSK9 Inhibition: The Final Word in Cholesterol Lowering? Robert A. Vogel, MD, FACC British Session Chairmen: Andreas Baumbach, MD, and Charles Ilsley, MD Evidence-based Primary Angioplasty: All Vessels, Just Heparin and no Aspiration? Andreas Baumbach, MD Advanced Cardiac Support The Harefield Experience Charles Ilsley, MD Cardiac Transplantation in the VAD Era Andre R. Simon, MD, PhD Remote Monitoring: Improving Care and Cost Effectiveness Mark Mason, MD The Heart of the Matter: Imaging Beyond the Myocyte Steven K. White, MD, PhD Atrial Fibrillation for the Interventionalist David Gareth Jones, BSc(Hons), MBBS, MD(Res) Management of Complex Aortic Coarctation and Re-coarctation Darryl Shore, MD Absorbable Stents in Clinical Practice: Importance of Post-market Evaluation in National Registries: ABSORB UK Andreas Baumbach, MD Swiss Session The Role of MRI in the Diagnosis of Coronary Artery Disease Michael Pieper, MD

13 Wednesday, March 9, :30 6:00 PM Afternoon Session Japanese Session Chairman: Hideo Nishikawa, MD, PhD Initial Experience of Japanese New DCA Device Etsuo Tsuchikane MD, PhD OCT/OFDI Guide to PCI in Japan Yoshihiro Morino, MD, PhD The Current Status and Future Perspective of TAVI Procedures in Japan Masanori Yamamoto, MD, PhD A Case of Very Small Annulus Size in Japanese Cohort ~ How Should We Manage? Masanori Yamamoto, MD, PhD CTO Update Etsuo Tsuchikane MD, PhD Japanese Multicenter Trials for Coronary Interventions Yoshihiro Morino, MD, PhD Central/Eastern European Session III: Structural Heart Disease Chairmen: Dariusz Dudek, MD, PhD, and Adam Witkowski, MD, PhD Do New Oral Anticoagulants Obviate the Need for LAA Exclusion? Latest Data from the Randomized Clinical Trials and Real Life Registries Marek Grygier, MD, PhD Watchman FLX: Design, Potential Benefits, and First Polish Clinical Experience with a New Device Marek Grygier, MD, PhD How to Prevent Complications of Transcatheter Left Atrial Appendage Closure: Experience with the First 100 Procedures Marcin Demkow, MD, PhD Subcutaneous Z Stitch for Hemostasis After large Caliber Femoral Venous Sheaths Removal A Randomized Comparison with Mutual Compression Marcin Demkow, MD, PhD Hemolysis on a Paravalvular Leak: Is it Still a Problem for Percutaneous Closure? Wojciech Wojakowski, MD

14 Comparison Between Transcatheter and Surgical Prosthesis Valve Implantation in Patients with Severe Aortic Stenosis Adam Witkowski, MD, PhD MSCT-guided TAVR Improves Outcomes in Patients with Aortic Stenosis: Tips and Tricks for Operators Radoslaw Parma, MD, PhD TAVR in Patients with Diabetes Mellitus: The Silesian Registry Andrzej Ochala, MD

15 Thursday, March 10, :00 10:00 AM Morning Session German Session Chairman: Gerald S. Werner, MD, PhD, FACC CTOs in Europe Have We Caught Up with the Japanese? Gerald S. Werner, MD, PhD, FACC Radiation Management for Complex PCI: It is the Operator, not the X-ray Machine that Does it Gerald S. Werner, MD, PhD, FACC FITTSTEMI Program: STEMI Treatment and Outcome in Germany in 2014/2015 Karl Heinrich Scholz, MD FITTSTEMI: Should we Really Forget about Thrombectomy in STEMI? Karl Heinrich Scholz, MD Atrial Fibrillation and Arteriosclerosis: Evaluating the Interface between Single, Dual, and Triple Therapy Hans-Friedrich Voehringer, MD, FACC Modern Treatment of Aortic Dissection Christoph A. Nienaber, MD, PhD, FACC Management of Adult Coarctation Christoph A. Nienaber, MD, PhD, FACC Australia/New Zealand Session Chairman: Patrick Kay, MD, PhD Pre-hospital Death and Ischemic Heart Disease: Insights from a National Data Linkage Study Patrick Kay, MD, PhD Should Primary PCI be Performed in the Very Old? David Clark, MBBS, DMedSci A Little Bit of EP MR Guided Catheter Ablation in EP Christopher Piorkowski, MD, PhD Implant-based isolation of pulmonary veins

16 Glenn Van Langenhove

17 Thursday, March 10, :30 6:00 PM Afternoon Session Dutch Session Chairman: Jacques J. Koolen, MD, PhD European Experience with the Mobius Carotid Device in the Treatment of Resistant Hypertension Jan Van der Heyden, MD, PhD New Oral Anticoagulants, Old Oral Anticoagulants, and PCI in Atrial Fibrillation: An Update Willem Dewilde, MD, PhD Finally Future-proof Results: FFR Pim A.L. Tonino, MD, PhD Ten Years of TAVI in The Netherlands Peter den Heijer, MD, PhD Lessons Learned from the Early Phase of BVS Implantation to Prevent Failures Georgios Vlachojannis, MD, PhD Absorbable Metal Scaffolds Jacques J. Koolen, MD, PhD A New Technology to Deliver a Self-apposing Stent: The Results of the SET-UP Study Karel T. Koch, MD, PhD One Year Results of the REMEDEE Registry: Clinical Outcomes with the COMBO Stent in a Multicenter, Prospective All-Comers Registry Robbert J. de Winter, MD, PhD Comparison of Impella 2.5 vs. 4.0 Guus Brueren, MD, PhD Central/Eastern European Session II: Structural Heart Disease (continued) Chairmen: Dariusz Dudek, MD, PhD, and Adam Witkowski, MD, PhD Anemia and Diabetes as the Risk Factors in Patients Undergoing TAVR: The POL-TAVI Registry Wojciech Wojakowski, MD Outcome of TAVR in Patients Over 90 Years Old Adam Witkowski, MD, PhD Breaking the Limits of TAVR: Polish Experience with the Newest Generation of Valves

18 Dariusz Dudek, MD, PhD

19 Friday, March 11, :00 10:00 AM Morning Session Oral Abstract Session IV Coronary Steal Phenomenon Due to an Un-litigated Branch of Lima Dhara Patel, MD Impact of Requirement for Transfusion on Cost of Care, Length of Stay and In-hospital Mortality in Percutaneous Mitral Balloon Valvuloplasty: A Propensity Score-matched Analysis Ronak Soni, MD Central/Eastern European Session III: Silesian Session Part 1 Chairmen: Andrzej Ochala, MD and Wojciech Wojakowski, MD Silesian Registry of CV Disease: Early and Late Outcomes, Effectiveness of Modern Treatment Mariusz G sior, MD, PhD Pl-AMI: National Registry of AMI Marek Gierlotka, MD, PhD Aborted AMI after Primary PCI: Definition, Prevalence, Early and Late Outcome Pawel Buszman, MD, PhD Early Discharge after STEMI and Primary PCI: How Short Hospital Stay is Really Short? Pawel Buszman, MD, PhD Telemonitoring After MI and Revascularization: Looking for New Protocols and Technology Krzysztof Milewski, MD, PhD Part 2 Chairmen: Pawel Buszman, MD, PhD and Mariusz G sior, MD, PhD Alcohol Renal Denervation: The Pilot Study and CE Registration of Pelegrine System Krzysztof Milewski, MD, PhD Novel, Biodegradable Polymer Sirolimus Eluting Stents - The Paradigm Shift Piotr Buszman, PhD, MD

20 Invasive Coronary Cardiac Procedures in Patients with Ischaemic Heart Failure - Old Problem, New Approach - Silesian Registry Mariusz G sior, MD, PhD Myocardial Regeneration: Preclinical and Clinical Programs in Silesia Wojciech Wojakowski, MD A look back over the past 31 years including video tapes of live cases, slide presentations from past meetings and a little bit of nostalgia. Discussion & Summary